Lymphocytes and macrophages in adipose tissue in obesity: markers or makers of subclinical inflammation?
Jazyk angličtina Země Rakousko Médium print-electronic
Typ dokumentu časopisecké články, přehledy
PubMed
28150048
DOI
10.1007/s00709-017-1082-3
PII: 10.1007/s00709-017-1082-3
Knihovny.cz E-zdroje
- Klíčová slova
- Adipocytes, Low-grade inflammation, Lymphocytes, Macrophages, Obesity,
- MeSH
- adipokiny metabolismus MeSH
- biologické markery metabolismus MeSH
- cytokiny metabolismus MeSH
- diabetes mellitus 2. typu etiologie MeSH
- lidé MeSH
- makrofágy imunologie MeSH
- myši MeSH
- obezita imunologie patologie MeSH
- T-lymfocyty pomocné-indukující imunologie MeSH
- tuková tkáň cytologie imunologie patologie MeSH
- zánět imunologie patologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- adipokiny MeSH
- biologické markery MeSH
- cytokiny MeSH
Obesity is accompanied by the development of chronic low-grade inflammation in adipose tissue. The presence of chronic inflammatory response along with metabolically harmful factors released by adipose tissue into the circulation is associated with several metabolic complications of obesity such as type 2 diabetes mellitus or accelerated atherosclerosis. The present review is focused on macrophages and lymphocytes and their possible role in low-grade inflammation in fat. Both macrophages and lymphocytes respond to obesity-induced adipocyte hypertrophy by their migration into adipose tissue. After activation and differentiation, they contribute to the development of local inflammatory response and modulation of endocrine function of adipose tissue. Despite intensive research, the exact role of lymphocytes and macrophages within adipose tissue is only partially clarified and various data obtained by different approaches bring ambiguous information with respect to their polarization and cytokine production. Compared to immunocompetent cells, the role of adipocytes in the obesity-related adipose tissue inflammation is often underestimated despite their abundant production of factors with immunomodulatory actions such as cytokines or adipokines such as leptin, adiponektin, and others. In summary, conflicting evidence together with only partial correlation of in vitro findings with true in vivo situation due to great heterogeneity and molecular complexity of tissue environment calls for intensive research in this rapidly evolving and important area.
Department of Obesitology Institute of Endocrinology Prague Czech Republic
Diabetes Centre Institute for Clinical and Experimental Medicine Prague Czech Republic
Zobrazit více v PubMed
J Biol Chem. 2011 Jan 21;286(3):1786-94 PubMed
Can J Physiol Pharmacol. 1997 Jul;75(7):789-95 PubMed
Nat Med. 2009 Aug;15(8):914-20 PubMed
Biochem Biophys Res Commun. 2010 Jan 15;391(3):1443-8 PubMed
J Lipid Res. 2005 Nov;46(11):2347-55 PubMed
Int J Obes (Lond). 2016 Jun;40(6):912-20 PubMed
FASEB J. 2017 Mar;31(3):868-881 PubMed
J Immunol. 2012 Mar 15;188(6):2592-601 PubMed
J Immunol. 1993 Jun 15;150(12):5576-84 PubMed
Nat Rev Immunol. 2012 Feb 17;12(3):180-90 PubMed
F1000Prime Rep. 2014 Mar 03;6:13 PubMed
N Engl J Med. 2003 Apr 24;348(17):1625-38 PubMed
Biochem Biophys Res Commun. 2005 Sep 9;334(4):1092-101 PubMed
Biochem Biophys Res Commun. 2004 Oct 15;323(2):630-5 PubMed
J Clin Invest. 2012 Mar;122(3):787-95 PubMed
Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18336-41 PubMed
Diabetologia. 2016 Mar;59(3):560-70 PubMed
FEBS Lett. 2005 Jul 4;579(17):3487-92 PubMed
J Exp Med. 1989 Dec 1;170(6):2081-95 PubMed
Diabetes. 2012 Feb;61(2):346-54 PubMed
Science. 1995 Jul 28;269(5223):543-6 PubMed
Nature. 1998 Aug 27;394(6696):897-901 PubMed
Am J Physiol. 1998 Jan;274(1 Pt 2):R204-8 PubMed
Cell Metab. 2013 Oct 22;:null PubMed
Immunobiology. 2014 Sep;219(9):695-703 PubMed
J Immunol. 1989 Nov 1;143(9):2806-13 PubMed
J Virol. 2000 May;74(10):4729-37 PubMed
J Immunol. 2012 Feb 1;188(3):1178-90 PubMed
Diabetes. 2001 Oct;50(10):2199-202 PubMed
Am J Physiol Endocrinol Metab. 2014 Aug 1;307(3):E289-304 PubMed
J Immunol. 2002 Apr 1;168(7):3536-42 PubMed
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19446-51 PubMed
Circ Res. 1998 Nov 16;83(10):1059-66 PubMed
Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1304-10 PubMed
Science. 2007 Aug 3;317(5838):666-70 PubMed
Nucleic Acids Res. 2012 Feb;40(4):1609-20 PubMed
Sci Signal. 2015 Mar 17;8(368):ra28 PubMed
Metabolism. 2008 Apr;57(4):488-93 PubMed
Nat Immunol. 2015 Jan;16(1):85-95 PubMed
Altern Med Rev. 2003 Aug;8(3):223-46 PubMed
Biomark Res. 2014 Jan 07;2(1):1 PubMed
FASEB J. 2006 Jul;20(9):1540-2 PubMed
J Innate Immun. 2010;2(4):316-24 PubMed
Biochem Biophys Res Commun. 2006 Dec 15;351(2):376-82 PubMed
Int J Obes (Lond). 2015 May;39(5):782-90 PubMed
J Nutr. 2004 Oct;134(10):2673-7 PubMed
Immunity. 2013 Apr 18;38(4):792-804 PubMed
Diabetes. 2004 May;53(5):1285-92 PubMed
JAMA. 2003 Jan 1;289(1):76-9 PubMed
Am J Physiol Endocrinol Metab. 2007 Mar;292(3):E740-7 PubMed
J Cell Physiol. 2011 Aug;226(8):2181-8 PubMed
Biochem Biophys Res Commun. 2003 Jan 10;300(2):472-6 PubMed
Circ Res. 2008 Aug 29;103(5):467-76 PubMed
Circulation. 2007 Feb 27;115(8):1029-38 PubMed
Nature. 1999 Jul 22;400(6742):378-82 PubMed
BMJ. 2000 Aug 12;321(7258):424 PubMed
Inflamm Bowel Dis. 1999 Nov;5(4):285-94 PubMed
J Clin Endocrinol Metab. 2001 Aug;86(8):3815-9 PubMed
Clin Chim Acta. 2013 Feb 18;417:80-4 PubMed
J Immunol. 2001 Feb 15;166(4):2173-7 PubMed
Int J Obes (Lond). 2011 Jan;35(1):91-8 PubMed
Endocrinology. 2011 Oct;152(10):3769-78 PubMed
Am J Physiol Regul Integr Comp Physiol. 2005 May;288(5):R1220-5 PubMed
J Exp Med. 2010 Feb 15;207(2):391-404 PubMed
Int J Obes (Lond). 2007 Sep;31(9):1420-8 PubMed
Sci Rep. 2011;1:76 PubMed
Nature. 2007 Jul 5;448(7149):44-9 PubMed
Angiogenesis. 2014 Jan;17 (1):109-18 PubMed
Cell Metab. 2013 Mar 5;17(3):411-22 PubMed
PLoS Comput Biol. 2009 Mar;5(3):e1000324 PubMed
Cell Metab. 2014 Jan 7;19(1):162-171 PubMed
Horm Metab Res. 2013 Sep;45(10):741-7 PubMed
Blood. 2006 Jun 15;107(12):4930-7 PubMed
In Vitro Cell Dev Biol Anim. 2013 Jun;49(6):473-8 PubMed
Physiol Res. 2004;53(2):123-9 PubMed
Gynecol Endocrinol. 2009 Apr;25(4):258-63 PubMed
Circulation. 1999 Dec 21-28;100(25):2473-6 PubMed
J Lipid Res. 1989 Dec;30(12):1917-23 PubMed
Nature. 2001 Jan 18;409(6818):307-12 PubMed
Cell Metab. 2016 Apr 12;23 (4):685-98 PubMed
PLoS One. 2015 Apr 20;10(3):e0122872 PubMed
Mol Cell Biochem. 2014 Mar;388(1-2):203-10 PubMed
Diabetes. 2010 May;59(5):1171-81 PubMed
Diabetes. 2014 Aug;63(8):2751-60 PubMed
Clin Dev Immunol. 2012;2012:925135 PubMed
Immunity. 2014 Apr 17;40(4):569-81 PubMed
Diabetologia. 2005 Nov;48(11):2330-3 PubMed
J Immunol. 2007 Feb 1;178(3):1748-58 PubMed
Diabetes. 2016 Sep;65(9):2516-28 PubMed
Diabetes. 2009 Nov;58(11):2525-35 PubMed
Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E1118-28 PubMed
J Immunol. 1995 May 15;154(10):5492-9 PubMed
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4854-8 PubMed
Science. 1996 Nov 22;274(5291):1379-83 PubMed
Infect Immun. 2012 Dec;80(12):4426-34 PubMed
Nat Med. 2001 Aug;7(8):941-6 PubMed
J Biol Chem. 2012 Oct 26;287(44):36896-904 PubMed
Diabetologia. 2009 Jun;52(6):1152-63 PubMed
FASEB J. 1998 Jan;12(1):57-65 PubMed
J Exp Med. 2004 Jun 7;199(11):1455-65 PubMed
Proc Natl Acad Sci U S A. 1995 Apr 11;92 (8):3348-52 PubMed
Vitam Horm. 2006;74:443-77 PubMed
Breast Cancer Res Treat. 2012 Feb;131(3):1003-12 PubMed
Endocrinology. 2010 Sep;151(9):4247-56 PubMed
Nat Immunol. 2015 Apr;16(4):376-85 PubMed
J Immunol. 1993 Nov 1;151(9):4545-51 PubMed
Eur J Immunol. 2008 Sep;38(9):2573-86 PubMed
J Clin Endocrinol Metab. 2004 Jun;89(6):2548-56 PubMed
Immunity. 2011 Apr 22;34(4):566-78 PubMed
Circulation. 2008 Feb 12;117(6):806-15 PubMed
J Immunol. 2011 Jan 1;186(1):25-31 PubMed
Exp Gerontol. 2007 Jun;42(6):463-71 PubMed
J Immunol. 2006 Jun 15;176(12):7745-52 PubMed
Diabetes. 2011 Feb;60(2):517-24 PubMed
Science. 2005 Jan 21;307(5708):426-30 PubMed
Arterioscler Thromb Vasc Biol. 2011 Oct;31(10 ):2322-30 PubMed
FEBS Lett. 2004 Aug 13;572(1-3):189-94 PubMed
Diabetes. 2004 May;53(5):1279-84 PubMed
Cell Mol Biol (Noisy-le-grand). 2001 Jun;47(4):619-35 PubMed
J Clin Invest. 2007 Jan;117(1):175-84 PubMed
J Immunol. 2004 Mar 1;172(5):2731-8 PubMed
Crit Rev Immunol. 1999;19(2):155-72 PubMed
J Immunol. 2001 Jul 15;167(2):995-1003 PubMed
J Mol Med (Berl). 2012 Feb;90(2):175-86 PubMed
Diabetes. 2007 Apr;56(4):901-11 PubMed
Physiol Res. 2010;59(1):79-88 PubMed
Diabetes. 2011 May;60(5):1504-11 PubMed
Nat Med. 2009 Aug;15(8):921-9 PubMed
PLoS One. 2013 Jun 18;8(6):e66515 PubMed
Trends Immunol. 2004 Dec;25(12):677-86 PubMed
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2017-21 PubMed
J Virol. 2002 Sep;76(18):9060-8 PubMed
J Leukoc Biol. 2016 Jun;99(6):1107-19 PubMed
J Obes. 2013;2013:291546 PubMed
Am J Respir Cell Mol Biol. 1999 Mar;20(3):474-80 PubMed
Am J Physiol Cell Physiol. 2007 Nov;293(5):C1481-8 PubMed
Cell Death Dis. 2016 Mar 31;7:e2167 PubMed
Immunol Res. 1999;20(2):147-61 PubMed
Immunol Rev. 2009 May;229(1):152-72 PubMed
Diabetes. 1998 Apr;47(4):515-22 PubMed
J Immunol. 1988 Apr 1;140(7):2121-7 PubMed
Curr Opin Lipidol. 2003 Jun;14(3):281-7 PubMed
Nature. 2007 Jun 28;447(7148):1116-20 PubMed
J Biol Chem. 2010 Feb 26;285(9):6153-60 PubMed
J Biol Chem. 2012 Apr 20;287(17):13561-71 PubMed
Int J Obes (Lond). 2015 May;39(5):762-9 PubMed
Neuroimmunomodulation. 2000;8(2):91-7 PubMed
Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1211-3 PubMed
J Transl Med. 2014 Sep 16;12:258 PubMed
Diabetol Metab Syndr. 2012 Sep 19;4(1):42 PubMed
Nat Med. 2011 May;17(5):610-7 PubMed
Eur J Endocrinol. 2003 Aug;149(2):129-35 PubMed
PLoS One. 2014 Apr 15;9(4):e94188 PubMed
J Clin Endocrinol Metab. 2009 Nov;94(11):4619-23 PubMed
Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5133-8 PubMed
Eur J Immunol. 2013 Aug;43(8):2089-100 PubMed
Obesity (Silver Spring). 2012 Jul;20(7):1372-8 PubMed
FASEB J. 2009 Mar;23(3):866-74 PubMed
J Clin Invest. 1995 May;95(5):2409-15 PubMed
Endocrinol Metab Clin North Am. 2008 Sep;37(3):753-68, x-xi PubMed